Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.
PolandAll drugs from this manufacturer
-
The vaccine is used to immunize adults and adolescents over 16 years of age against hepatitis A virus (HAV).
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage hepatitis a virus gbm strain inactivated 160 antigenic units ATC: J07BC02
-
The vaccine is used to prevent poliomyelitis (polio) in infants, children, adolescents, and adults. It may be used as part of a primary vaccination schedule or as a booster dose.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage poliovirus type 1 mahoney strain inactivated 29 units of antigen D inactivated poliomyelitis vaccine 0.5 ml poliovirus type 2 mef-1 strain inactivated 7 units of antigen D poliovirus type 3 sabin strain inactivated 26 units of antigen D ATC: J07BF03
-
The vaccine helps protect the child against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio).
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid minimum 30 IU tetanus toxoid minimum 40 IU bordetella pertussis antigens 25 micrograms poliovirus type 1 mahoney strain inactivated 40 units of antigen D poliovirus type 2 mef-1 strain inactivated 8 units of antigen D poliovirus type 3 sabin strain inactivated 32 units of antigen D ATC: J07CA02
-
The vaccine helps protect adults, adolescents, and children over 2 years of age against typhoid fever, which is caused by the Salmonella typhi bacterium.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage purified vi capsular polysaccharide of salmonella typhi (ty2 strain) 25 mcg ATC: J07AP
-
The vaccine is used to protect adults and children (from 6 months of age) against influenza. It helps the immune system produce antibodies that protect against three strains of the virus.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage a/victoria/4897/2022 (h1n1)pdm09 influenza virus strain No input provided influenza a virus strain a/croatia/10136rv/2023 (h3n2) No input provided influenza virus b/austria/1359417/2021 strain No input provided ATC: J07BB02
-
This is a vaccine that helps protect adults and children (from 6 months of age) against influenza. It helps the body produce antibodies that protect against four strains of the virus.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage inactivated split influenza virus containing strains a/victoria/4897/2022 (h1n1)pdm09 a/darwin/9/2021 (h3n2) b/austria/1359417/2021 b/phuket/3073/2013 No input provided ATC: J07BB02
-
The vaccine is used to prevent rabies both before and after exposure to the virus. It is intended for all age groups.
Dosage form: powder and solvent for preparation of suspension for injection
Active substance Dosage rabies virus wistar rabies pm/wi38 1503-3m inactivated not less than 2.5 IU rabies virus wistar rabies pm/wi38 1503-3m inactivated No input provided ATC: J07BG01